Patents Assigned to Abbott Diabetes Care Inc.
  • Patent number: 11835479
    Abstract: Embodiments that translate a sensor measurement to a frequency characteristic are disclosed. The frequency characteristic can be wirelessly detected by a reader device. The detected frequency characteristic can be used to determine the corresponding sensor measurement. Devices utilizing this approach can be characterized or calibrated to increase accuracy. Systems and methods utilizing the approaches are also described.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: December 5, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Lei He, Michael R. Love
  • Patent number: 11828748
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Grant
    Filed: May 3, 2022
    Date of Patent: November 28, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Publication number: 20230365758
    Abstract: Membranes permeable to an analyte may overlay the active sensing region of a sensor to limit the analyte flux and improve the response linearity of the sensor. Temperature variation of the analyte permeability can be problematic in some instances. Polymeric membrane compositions having limited variation in analyte permeability as a function of temperature may comprise: a polymer backbone comprising one or more side chains that comprise a heterocycle; and an amine-free polyether arm appended, via an alkyl spacer or a hydroxy-functionalized alkyl spacer, to the heterocycle of at least a portion of the one or more side chains.
    Type: Application
    Filed: April 21, 2023
    Publication date: November 16, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Balasubrahmanya S. BOMMAKANTI, John V. LATOUR, Udo HOSS, Tianmei OUYANG, Phu LE, Gary SANDHU, Kevin WALLIS
  • Patent number: 11806141
    Abstract: Glucose monitoring devices and related systems and methods, the glucose monitoring devices including a sensor electronics unit having a housing and a printed circuit board disposed within the housing, a transcutaneous glucose sensor assembly, and a conductive sensor connector. The printed circuit board includes a first electrical contact, the transcutaneous glucose sensor assembly includes a distal portion having a working electrode and proximal portion having a working-electrode contact in electrical communication with the working electrode, and the conductive sensor connector electrically connects the working-electrode contact with the first electrical contact. Further, the conductive sensor connector extends through a hole in the proximal portion of the transcutaneous glucose sensor assembly and through a hole in the printed circuit board.
    Type: Grant
    Filed: September 12, 2022
    Date of Patent: November 7, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Mohammad E. Moein, Louis G. Pace, Udo Hoss, Phu X. Le, Samuel Mason Curry
  • Patent number: 11806110
    Abstract: Methods and systems for providing therapy related data management are provided. The subject systems include one or more device components, and at least one memory storage unit and at least one data storage unit associated with such one or more device components. The device components may include one or more of an analyte monitoring system, a fluid delivery device and a remote terminal. The subject methods include use of the subject systems to optimize treatment of a patient.
    Type: Grant
    Filed: September 19, 2022
    Date of Patent: November 7, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventor: R. Curtis Jennewine
  • Publication number: 20230346269
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: June 23, 2023
    Publication date: November 2, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Publication number: 20230352126
    Abstract: Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.
    Type: Application
    Filed: July 12, 2023
    Publication date: November 2, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
  • Patent number: 11793936
    Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: October 24, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
  • Patent number: 11793427
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: October 24, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
  • Patent number: 11789008
    Abstract: Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: October 17, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Michael R. Love, Michael J. Fullmer, Kurt E. Leno, Xuandong Hua, Mark Sloan, Lei He, Glenn Berman
  • Publication number: 20230320626
    Abstract: An analyte measurement device including an analyte sensor configured to measure an analyte level, the analyte sensor including a tail portion for subcutaneous placement, the tail portion having an analyte-responsive enzyme disposed thereon; an applicator for delivery of the analyte sensor, the applicator having a housing defining a hermetically-sealed chamber, the tail portion disposed within the chamber prior to subcutaneous placement; and a scavenger material disposed within the chamber, the scavenger material comprising at least one of activated carbon, molecular sieve, and silica gel and configured to adsorb at least one substance within the chamber. A method of packaging an analyte sensor is also disclosed.
    Type: Application
    Filed: March 16, 2023
    Publication date: October 12, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Louis Pace, Jean-Pierre Cole, Udo Hoss, Steven Mitchell, Matthew Simmons
  • Publication number: 20230326565
    Abstract: Embodiments described herein include a glucose monitoring system. The glucose monitoring system is configured to use various methods and additional systems to facilitate the transfer of glucose data from a data receiving device without wireless network capabilities. Certain embodiments facilitate the transfer of data to multi-purpose devices, user devices, and electronic medical records (EMR) systems. Certain embodiments facilitate the transfer of data to report generating systems that interpret the provided data and reports based on the glucose data. Certain embodiments relate to techniques for facilitating the integration of EMR system data management and reporting.
    Type: Application
    Filed: April 6, 2023
    Publication date: October 12, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Roy Tsuchida
  • Patent number: 11783941
    Abstract: Methods, devices, and kits are provided for determining a compatibility of one or more devices in an analyte monitoring system.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: October 10, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Andrew H. Naegeli
  • Patent number: 11779248
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: October 10, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Publication number: 20230317276
    Abstract: Method and apparatus including calling, retrieving and/or initiating a programmed function in conjunction with execution of one or more commands related to a closed loop control algorithm, receiving one or more data in response to the one or more commands over a data interface, and executing the one or more commands related to the closed loop control algorithm based on the received one or more data are provided.
    Type: Application
    Filed: April 3, 2023
    Publication date: October 5, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc Barry TAUB, Daniel Milfred BERNSTEIN, Gary Alan HAYTER, Mark Kent SLOAN, Glenn Howard BERMAN, Saeed NEKOOMARAM
  • Patent number: 11770210
    Abstract: Disclosed herein are methods and systems for receiving an encoded data packet, one or more activation commands, and a communication identifier, decoding the received data packet, validating the decoded received data packet, and executing one or more routines associated with the respective one or more activation commands.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: September 26, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jeffery M. Sicurello, Mark K. Sloan
  • Patent number: D1001152
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: October 10, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Panganamala Ashwin Kumar, Joel Goldsmith
  • Patent number: D1002852
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: October 24, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Matthew Simmons, Peter Robinson, Vivek Rao
  • Patent number: D1004598
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: November 14, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: William Lee, Andrew Revoltar, Panganamala Ashwin Kumar, Steven Stratis, Lindsey Colleen Swinehart
  • Patent number: D1006235
    Type: Grant
    Filed: April 4, 2023
    Date of Patent: November 28, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Vivek Rao, Steven T. Mitchell, Matthew Simmons